This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (96)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cognitive Therapy  • Public Health  • Substance Abuse/ Alcoholism  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

A Randomized Placebo-Controlled Trial

Kathleen M. Carroll, PhD; Lisa R. Fenton, PsyD; Samuel A. Ball, PhD; Charla Nich, MS; Tami L. Frankforter, BS; Julia Shi, MD; Bruce J. Rounsaville, MD

Arch Gen Psychiatry. 2004;61:264-272.

Context  Disulfiram has emerged as a promising treatment for cocaine dependence, but it has not yet been evaluated in general populations of cocaine users.

Objectives  To compare the effectiveness of disulfiram therapy with that of a placebo condition in reducing cocaine use and to compare the effectiveness of 2 active behavioral therapies—cognitive behavior therapy (CBT) and interpersonal psychotherapy (IPT)—in reducing cocaine use.

Design  Randomized, placebo-controlled, double-masked (for medication condition), factorial (2 x 2) trial with 4 treatment conditions: disulfiram plus CBT, disulfiram plus IPT, placebo plus CBT, and placebo plus IPT.

Setting  A community-based outpatient substance abuse treatment program.

Patients  A total of 121 individuals meeting the criteria for current cocaine dependence.

Interventions  Patients received either disulfiram (250 mg/d) or placebo in identical capsules. Medication compliance was monitored using a riboflavin marker procedure. Both behavioral therapies (CBT and IPT) were manual guided and were delivered in individual sessions for 12 weeks.

Main Outcome Measures  Random regression analyses of self-reported frequency of cocaine use and results of urine toxicology screens.

Results  Participants assigned to disulfiram reduced their cocaine use significantly more than those assigned to placebo, and those assigned to CBT reduced their cocaine use significantly more than those assigned to IPT (P<.01 for both). Findings were consistent across all study samples (eg, intention to treat, treatment initiators, and treatment completers). Benefits of disulfiram use and CBT were most pronounced for participants who were not alcohol dependent at baseline or who fully abstained from drinking alcohol during treatment. Adverse effects experienced by participants who received disulfiram were mild and were not considerably different from those experienced by participants who received placebo.

Conclusions  Disulfiram and CBT are effective therapies for general populations of cocaine-dependent individuals. Disulfiram seems to exert a direct effect on cocaine use rather than through reducing concurrent alcohol use.

From the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence-based treatments of addiction
O'Brien
Phil Trans R Soc B 2008;363:3277-3286.
ABSTRACT | FULL TEXT  

A Promising Debut for Computerized Therapies
Greist
Am. J. Psychiatry 2008;165:793-795.
FULL TEXT  

Treatment Retention and Outcome Among Cocaine-Dependent Patients With and Without Active Criminal Justice Involvement
Easton et al.
J Am Acad Psychiatry Law 2007;35:83-91.
ABSTRACT | FULL TEXT  

Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs
McCarty et al.
Psychiatr. Serv. 2007;58:181-190.
ABSTRACT | FULL TEXT  

Preclinical Development and Clinical Implementation of Treatments for Substance Abuse Disorders
Pechnick et al.
Focus 2007;5:151-162.
ABSTRACT | FULL TEXT  

Bibliography for Substance Abuse: Diagnosis and Treatment
Focus 2007;5:184-186.
FULL TEXT  

Abstracts for Substance Abuse: Diagnosis and Treatment
Focus 2007;5:187-192.
FULL TEXT  

DISULFIRAM, COCAINE, AND ALCOHOL: TWO OUTCOMES FOR THE PRICE OF ONE?
GOSSOP and CARROLL
Alcohol Alcohol 2006;41:119-120.
FULL TEXT  

Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes.
Sinha et al.
Arch Gen Psychiatry 2006;63:324-331.
ABSTRACT | FULL TEXT  

Anticraving Medications for Relapse Prevention: A Possible New Class of Psychoactive Medications
O'Brien
Am. J. Psychiatry 2005;162:1423-1431.
ABSTRACT | FULL TEXT  

Medication Development for Addictive Disorders: The State of the Science
Vocci et al.
Am. J. Psychiatry 2005;162:1432-1440.
ABSTRACT | FULL TEXT  

Stimulant use still going strong: REVISITING... MISUSE OF AMPHETAMINES AND RELATED DRUGS
Seivewright et al.
Adv. Psychiatr. Treat. 2005;11:262-269.
ABSTRACT | FULL TEXT  

Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Kreek et al.
Pharmacol. Rev. 2005;57:1-26.
ABSTRACT | FULL TEXT  

The Effectiveness of Telephone-Based Continuing Care for Alcohol and Cocaine Dependence: 24-Month Outcomes
McKay et al.
Arch Gen Psychiatry 2005;62:199-207.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
 

Other articles noted
Evid. Based Med. 2004;9:127-128.
FULL TEXT  

Is Buprenorphine Useful for Cocaine Dependence? Is Disulfiram?
JWatch Psychiatry 2004;2004:7-7.
FULL TEXT